TSX:EXEHealthcare
Assessing Extendicare (TSX:EXE) Valuation After Strong 2025 Results Dividend Hike And CBI Home Health Deal
Extendicare (TSX:EXE) just paired strong 2025 earnings with a 5% monthly dividend increase and a planned $570 million acquisition of CBI Home Health, which puts its home care expansion and income profile in focus.
See our latest analysis for Extendicare.
The share price reaction has been strong, with a 10.06% 1 day share price return and 29.47% 90 day share price return lifting Extendicare to CA$26.58. The 1 year total shareholder return of 121.11% and 5 year total shareholder return of...